Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AE37 |
| Synonyms | |
| Therapy Description |
AE37 is an Erbb2 (Her2) peptide vaccine, linked to li-Key peptide and combined with GM-CSF, that potentially induces T-cell activation and results in anti-tumor immune response (PMID: 18612158, PMID: 27029708). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AE37 | AE37 Peptide GM-CSF Vaccine | HER2 (ERBB2) Vaccine 15 | AE37 is an Erbb2 (Her2) peptide vaccine, linked to li-Key peptide and combined with GM-CSF, that potentially induces T-cell activation and results in anti-tumor immune response (PMID: 18612158, PMID: 27029708). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|